Company intelligence / Profile preview

SpringLeaf Therapeutics

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

SpringLeaf Therapeutics ceased operations in January 2015 after raising over $20 million without successfully advancing its device to clinical trials. The company spent most of its lifespan attempting to perfect a complex battery-powered delivery system but encountered difficulties in reducing device size, securing partner interest, and obtaining regulatory pathway clarity.

Therapeutic areas: CardiovascularImmunology
Modalities: Device (wearable pump system for drug delivery)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on SpringLeaf Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpringLeaf Therapeutics.

Explore the full profile